Skip to main content

All News

Aug 17, 2009

Influenza A H1 N1 Update

The CVM is an integral part of the frontline involved in North Carolina preparedness for infectious diseases affecting humans or animals. As part of their public engagement activity, for example, the Epidemiology, Public Health, and Population Medicine faculty members have been monitoring the current influenza situation and are working with federal and state officials in… 

Aug 17, 2009

Dr. Horowitz on Jimmy V Cancer Training Program

[section_subtitle]What is the significance of this program? [/section_subtitle] Federal agencies (National Science Board, National Academy of Science, and National Institutes of Health) and private-sector interest groups (Council on Competitiveness) have warned of a crisis in U.S. science education and a loss of national competitiveness in science and technology. Compared with peers around the world, fewer… 

Jul 28, 2009

CVM Evaluates New Drug to Treat Canine Epilepsy

North Carolina State University’s College of Veterinary Medicine (CVM) is participating in a national clinical trial evaluating a new drug to treat canine idiopathic epilepsy— a chronic condition affecting some four million dogs that is characterized by recurring seizures for which an underlying cause has not been identified. The largest clinical trial of its kind,… 

Jul 20, 2009

Researchers Study Imprinted Genes for Clues to Fetal Growth Restriction in Cloned Swine

Researchers at North Carolina State University’s Center for Comparative Medicine and Translational Research have found that intrauterine growth restriction (IUGR), which results in low birth weight and long-term deleterious health effects in cloned swine, is linked to a type of gene – known as an imprinted gene – found only in placental mammals. Imprinted genes… 

Jul 15, 2009

CVM Receives AAALAC Commendation, Accreditation

The College of Veterinary Medicine has received commendation and full accreditation from AAALAC—the Association for Assessment and Accreditation of Laboratory Animal Care—following a recent site visit. In a letter to Dr. Rick Fish, director of the CVM Laboratory Animal Resources unit, Dr. John Bradfield, president of the AAALAC Council on Accreditation, wrote: “Especially noteworthy were… 

Jul 13, 2009

Clinical Studies Core Advances VTH Research

Continued development of the clinical investigations program within the Center for Comparative Medicine and Translational Research (CCMTR) is being supported by a $625,000 gift from Novartis Animal Health US, Inc. and the recent addition of Dr. Kim Chappell who has joined the CCMTR to lead the Clinical Studies Core. The role of the Clinical Studies… 

Jul 13, 2009

Canine Spinal Cord Injury Program Tests New Drug

The Canine Spinal Cord Injury Program at North Carolina State University’s Veterinary Teaching Hospital is evaluating the efficacy of a drug being developed to improve hind limb function in chronically paralyzed dogs. The drug, a novel potassium channel antagonist or blocker, showed promise in a preliminary trial in dogs with spinal cord injuries. The clinical… 

Jul 13, 2009

Dean Arden Appointed AAVMC President

Dr. Warwick Arden, Interim Provost and Executive Vice Chancellor of NC State University and Dean of the College of Veterinary Medicine, has been named president of the Association of American Veterinary Medical Colleges (AAVMC). The appointment for the 2009-2010 term is effective immediately. The AAVMC coordinates the affairs of veterinary colleges in the United States, Canada,… 

Jul 7, 2009

CCMTR-led Research Team Seeking Brain Tumor Gene

Pinpointing the genes involved in human brain cancer can be like looking for a needle in a haystack, and sometimes the needle you find may not be the right one. By comparing human and canine genomes, researchers at North Carolina State University have discovered that a gene commonly believed to be involved in meningiomas—tumors that… 

May 30, 2009

Dermatology Service Conducts Clinical Trial

The Veterinary Teaching Hospital’s Dermatology Service is the lead center of a 12-week, multiple facility clinical trial that seeks to determine the optimal dose of the drug antifolate aminopterin in treating dogs with moderate atopic dermatitis—a common allergic skin disease. The trial continues an earlier “proof-of-concept” pilot study conducted by the Veterinary Teaching Hospital (VTH)…